Friday, 10 November 2023
Lest We Forget: Veterans Day Remembrance
https://todaylogic.blogspot.com/
A recent study published in the journal JAMA Neurology found that people with elevated NfL levels had a higher risk of worsening disability, even if they had no clinical relapse. The study also found that NfL levels started to rise up to two years before disability worsened.
This suggests that the NfL blood test could be used to identify people with MS who are at risk of worsening disability. This information could be used to guide treatment decisions and to help people with MS plan for the future.
The NfL blood test is not yet widely available, but it is currently being used in research studies. It is hoped that the test will be more widely available in the future.
A recent study published in the journal JAMA Neurology found that people with elevated NfL levels had a higher risk of worsening disability, even if they had no clinical relapse. The study also found that NfL levels started to rise up to two years before disability worsened.
This suggests that the NfL blood test could be used to identify people with MS who are at risk of worsening disability. This information could be used to guide treatment decisions and to help people with MS plan for the future.
The NfL blood test is not yet widely available, but it is currently being used in research studies. It is hoped that the test will be more widely available in the future.
This suggests that the NfL blood test could be used to identify people with MS who are at risk of worsening disability. This information could be used to guide treatment decisions and to help people with MS plan for the future.
The NfL blood test is not yet widely available, but it is currently being used in research studies. It is hoped that the test will be more widely available in the future.
A recent study published in the journal JAMA Neurology found that people with elevated NfL levels had a higher risk of worsening disability, even if they had no clinical relapse. The study also found that NfL levels started to rise up to two years before disability worsened.
This suggests that the NfL blood test could be used to identify people with MS who are at risk of worsening disability. This information could be used to guide treatment decisions and to help people with MS plan for the future.
The NfL blood test is not yet widely available, but it is currently being used in research studies. It is hoped that the test will be more widely available in the future.